refelctions on the role of pharmacogenomic biomarkers in drug labels - lawrence lesko, ph.d., f.c.p.
Published 9 years ago • 411 plays • Length 51:11Download video MP4
Download video MP3
Similar videos
-
1:02:32
pharmacogenomics: discovery and translation
-
5:45
pharmacogenomics ~direct-to-consumer genetic testing~ (23andme)
-
43:45
pharmacogenomics: genomics and drug response - richard weinshilboum, m.d.
-
1:00
mayo clinic minute: pharmacogenomics is individualizing medicine
-
7:20
pharmacogenomics: genes and medicine
-
1:02:05
recent advances in pharmacogenomics | laboratory medicine and pathology in individualized medicine
-
9:50
the role of pharmacodynamic biomarkers in biosimilar drug development
-
1:00:16
implementation of preemptive clinical pharmacogenetics
-
14:25
episode 10: ending levothyroxine overprescriptions
-
13:27
pharmacokinetics: drug absorption and distribution
-
32:17
dr. ola engkvist, ph.d. - astrazeneca - head, molecular ai, discovery sciences, r&d
-
35:39
bioaccomulation of pharmaceuticals or organic electrolytes in the environment
-
29:26
predicting outcomes in ra - the role of biomarkers
-
5:10
1. pharmacogenetics in action
-
34:22
a guide to pharmacogenomic resources: what clinicians should know
-
8:24
pharmacogenomics: precision medicine & drug response
-
0:50
lovisa afzelius: what we’re working on
-
44:02
chemical characterization: the starting point for biological evaluations
-
3:30
pharmacogenomic testing – karen's story
-
18:55
finding disease-causing complex mutations | martin frith
-
48:06
when does it make sense to get a pharmacogenomic test?